CAS: 55758-02-6; 3-Bromopicolinonitrile

相似化合物

30683-23-9 405174-97-2 36057-54-2

上下游产品

CAS号2402-97-3 3-溴吡啶-N-氧化物 | CAS号7677-24-9 三甲基氰硅烷 | CAS号626-55-1 3-溴吡啶 | CAS号151-50-8 氰化钾 | CAS号30683-23-9 3-溴-2-吡啶羧酸 | CAS号67967-11-7 1,7-萘啶-8(7H)-酮 | CAS号53636-56-9 3-溴吡啶甲酸甲酯 | CAS号14623-54-2 3-巯基甲酸吡啶盐酸盐 | CAS号178811-41-1 3-(叔丁基硫代)吡啶-2-羧酸 | CAS号178811-40-0 3-叔丁硫基-2-氰基吡啶 | CAS号1214340-31-4 3-(4-氟苯基)吡啶-2-甲腈 | CAS号625826-72-4 3-propan-2-ylsu... | CAS号52817-50-2 6H-benzo[f][1,7...

3-溴吡啶-N-氧化物 反应生成 3-溴-2-氰基吡啶
参考文献:Fused Heterocyclic Succinimide Compounds And Analogs Thereof,Modulators Of Nuclear Hormone Receptor Function
标题:Fused Heterocyclic Succinimide Compounds And Analogs Thereof,Modulators Of Nuclear Hormone Receptor Function
摘要:融合的环化合物,使用这种化合物治疗与核激素受体相关的疾病,如癌症和免疫紊乱的方法,以及含有这种化合物的药物组合物.

专利信息

专利号:US-2024383920-A1
优先权日:2023-04-14
标 题:Synthesis of ras inhibitors
发明人：LI SHAOLING; LL YI; LOBBEN PAUL; WANG ROSS; BALLMER STEVE; HUANG XIAOJUN
权利人:REVOLUTION MEDICINES INC
摘要:The present invention relates to Ras inhibitors and to methods for preparing Ras inhibitors.

专利号:US-8633182-B2
优先权日:2012-05-30
标题:Indanyloxyphenylcyclopropanecarboxylic acids
发明人：HAMPRECHT DIETER; FRATTINI SARA; LINGARD IAIN; PETERS STEFAN
权利人:HAMPRECHT DIETER; FRATTINI SARA; LINGARD IAIN; PETERS STEFAN; BOEHRINGER INGELHEIM INT
摘要:The present invention relates to compounds of general formula I, n nwherein the groups R 1 , R 2 , R 3 , m and n are defined as in claim 1 , which have valuable pharmacological properties, in particular bind to the GPR40 receptor and modulate its activity. The compounds are suitable for treatment and prevention of diseases which can be influenced by this receptor, such as metabolic diseases, in particular diabetes type 2. Furthermore, the invention relates to novel intermediates, useful for the synthesis of compounds of formula I.

专利号:WO-2010096722-A1
优先权日:2009-02-20
标 题 :3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors
发明人：FENG JUN; KEUNG WALTER; NOTZ WOLFGANG REINHARD LUDWIG
权利人:TAKEDA PHARMACEUTICAL; FENG JUN; KEUNG WALTER; NOTZ WOLFGANG REINHARD LUDWIG
摘要:Claimed are intermediates in the synthesis of N-Arylmethyl-3-Oxo-2,3-dihydro- [1,2,4]triazolo[4,3-a]pyridine-6-carboxamides as well as a process (A) to arrive at 3-Oxo-2, 3-dihydro-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid. The triazolo[4,3-a]pyridine-6-carboxamides of formula (I) are used as soluble epoxide hydrolase inhibitors (sEH) having therapeutic effect in pathologic conditions such as hypertension, stroke, inflammatory processes, diabetes and a variety of cardiovascular diseases.

专利号:WO-2024216017-A2
优先权日:2023-04-14
标题:Synthesis of ras inhibitors

专利号:WO-2024216008-A1
优先权日:2023-04-14
标题 :Synthesis of ras inhibitors

专利号:TW-202442230-A
优先权日:2023-04-14
标 题 :Synthesis of ras inhibitors